The Pox Virion Molecular Interactome
痘病毒体分子相互作用组
基本信息
- 批准号:8582931
- 负责人:
- 金额:$ 21.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-09 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:AfricaAgricultureAnimalsAntibodiesAntiviral AgentsAppearanceApplications GrantsArchitectureAreaBindingBoxingCapsid ProteinsComplementComplexCore ProteinDNA BindingDevelopmentDiseaseDisease OutbreaksEnzymesEquipment and supply inventoriesFamilyFamily PicornaviridaeFutureGenetic TranscriptionGenomeHerpesviridaeHeterogeneityHumanIn SituInterventionKnowledgeLateralMass Spectrum AnalysisMediatingMedicalMethodologyMolecularMolecular StructureMonkeypoxNormal Pressure HydrocephalusNuclear Pore ComplexNucleoproteinsNucleosomesPeptidesPositioning AttributePoxviridaeProteinsRNA Polymerase IIRNA VirusesResolutionRiskRoleRouteShapesSmallpoxSolubilityStagingStructural ProteinStructureTechniquesTestingTextilesTherapeuticTherapeutic AgentsVacciniaVacciniumVirionVirusVirus DiseasesYeastsanthrax lethal factorbasecrosslinkdesignmulticatalytic endopeptidase complexnovelparticleprotein complexprotein crosslinkprotein protein interactionpublic health relevancetherapeutic vaccinetooltransmission processvirus envelopeyeast two hybrid system
项目摘要
DESCRIPTION (provided by applicant): Smallpox has, historically, been one of the great killers of mankind. Although this disease is considered to have been eradicated some 35 years ago, the poxviruses, nonetheless, comprise a major family of viruses of medical, ecological and agricultural importance. For humans, aside from the possibility of smallpox re-introduction, eradication has coincided with the appearance of human monkeypox in Africa during the past 40 years and in the US during the past decade. Not knowing the lethal factor in smallpox, the full potential of such outbreaks remains uncertain. The importance of virus envelopes and capsid proteins in mediating the effects of antiviral therapeutics and vaccines is undisputed. From the picornaviruses to the herpesviruses, an understanding of virion outer molecular structures at molecular or atomic resolution, has instructed the rational design of therapeutic agents and an understanding of mechanisms that cause and thwart virus infection and disease. Due to their complexity, asymmetry and heterogeneity, the poxviruses have, however, been particularly persistent in defeating attempts to understand their virion structure at the molecular
level, thus evading an important potential avenue for intervention. The P.I. hypothesizes that the complexity of the vaccinia virion may prove to be an Achilles heel. In addition, a full understanding of virion structure may be regarded as one of the last remaining black boxes in the lifecycle of the poxviruses - one which impinges upon the early transcription, genome uncoating and virion assembly stages of poxvirus replication. The major hole in our knowledge of pox virion structure lies at a level between the inventory of proteins present within the virion
(which is largely known) and the basic topological and topographical features of the intact particle (also known). This intervening area may be referred to as the virion's "molecular architecture", or protein "interactome". In this R21 proposal, the P.I. has chosen a protein-protein crosslinking approach in combination with mass spectrometry. Such an approach for interactome analysis is unbiased in many respects, and has a track record of informing the molecular architectures of elaborate cellular assemblies such as the nuclear pore complex, 20S proteasome and RNA polymerase II. Aim 1 of this proposal seeks to identify directly juxtaposed proteins within the virion core via covalent protein-protein crosslinking/MS, taking "top-down" (protein-level) and "bottom-up" (peptide-level) approaches. The P.I. hypothesizes that the pox virion core wall may not be fundamentally dissimilar to the matrix protein layers of some enveloped RNA viruses, and that the classical delineation of enzymes in the deep interior with structural proteins surrounding may not be as clear cut as currently supposed.
描述(由申请人提供):从历史上看,天花一直是人类的伟大杀手之一。尽管大约35年前被认为已经消除了这种疾病,但尽管如此,痘病毒还是构成了医学,生态和农业重要性的主要病毒家族。对于人类而言,除了天花再入学的可能性外,根除与过去40年中非洲人类蒙基托克斯(Monkeypox)的出现相吻合,在过去的十年中。不知道天花中的致命因素,这种暴发的全部潜力仍然不确定。毫无疑问,病毒信封和衣壳蛋白在介导抗病毒疗法和疫苗的作用中的重要性。从Picornaviruse到疱疹病毒,对分子或原子分辨率下的病毒体外分子结构的理解都指示了治疗剂的合理设计以及对引起病毒感染和疾病的机制的理解。然而,由于它们的复杂性,不对称和异质性,痘病毒尤其持续到失败的尝试以理解分子的病毒体结构的尝试
水平,从而避开了重要的干预潜在途径。 P.I.假设离甲酸的复杂性可能被证明是阿喀琉斯高跟鞋。此外,对病毒体结构的完全理解可能被视为鼠类生命周期中最后一个剩余的黑匣子之一,这种黑匣子会影响早期转录,基因组脱落和病毒式复制阶段。我们对痘病毒结构的知识的主要漏洞在于病毒体中存在的蛋白质库存之间
(在很大程度上是已知的)以及完整粒子(也已知)的基本拓扑和地形特征。该中间区域可以称为Virion的“分子结构”或蛋白质“ Interactome”。在此R21提案中已经选择了一种结合质谱法结合使用蛋白质 - 蛋白质交联方法。这种进行相互作用分析的方法在许多方面都公正,并且具有通知详细的细胞组件分子体系结构(例如核孔复合物,20S蛋白酶体和RNA聚合酶II)的记录。该提案的目标1旨在通过共价蛋白质 - 蛋白交联/MS来鉴定病毒核内核直接并置的蛋白质,以“自上而下”(蛋白质级)和“自下而上)和“自下而上”(肽级)方法。 P.I.假设的是,痘病毒核壁可能与某些包裹的RNA病毒的基质蛋白层没有根本不同,并且在深层内部具有结构性蛋白质周围结构蛋白的经典描述可能不会像当前那样清晰。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul D Gershon其他文献
Paul D Gershon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul D Gershon', 18)}}的其他基金
Nuclear functions co-opted by human rhinovirus during replication in the cytoplasm of infected cells
人鼻病毒在受感染细胞的细胞质中复制过程中选择的核功能
- 批准号:
10684733 - 财政年份:2021
- 资助金额:
$ 21.73万 - 项目类别:
Nuclear functions co-opted by human rhinovirus during replication in the cytoplasm of infected cells
人鼻病毒在受感染细胞的细胞质中复制过程中选择的核功能
- 批准号:
10443844 - 财政年份:2021
- 资助金额:
$ 21.73万 - 项目类别:
Nuclear functions co-opted by human rhinovirus during replication in the cytoplasm of infected cells
人鼻病毒在受感染细胞的细胞质中复制过程中选择的核功能
- 批准号:
10298555 - 财政年份:2021
- 资助金额:
$ 21.73万 - 项目类别:
Molecular architecture of the Vaccinia virion by structural proteomics
通过结构蛋白质组学研究牛痘病毒粒子的分子结构
- 批准号:
10179428 - 财政年份:2019
- 资助金额:
$ 21.73万 - 项目类别:
Molecular architecture of the Vaccinia virion by structural proteomics
通过结构蛋白质组学研究牛痘病毒粒子的分子结构
- 批准号:
10465049 - 财政年份:2019
- 资助金额:
$ 21.73万 - 项目类别:
Molecular architecture of the Vaccinia virion by structural proteomics
通过结构蛋白质组学研究牛痘病毒粒子的分子结构
- 批准号:
10022126 - 财政年份:2019
- 资助金额:
$ 21.73万 - 项目类别:
Novel nuclear and intracellular pathology in early AD
AD 早期的新核和细胞内病理学
- 批准号:
8702666 - 财政年份:2014
- 资助金额:
$ 21.73万 - 项目类别:
LTQ Velos Pro mass spectrometer with ETD and other options
具有 ETD 和其他选件的 LTQ Velos Pro 质谱仪
- 批准号:
8447950 - 财政年份:2013
- 资助金额:
$ 21.73万 - 项目类别:
相似国自然基金
农业废弃物好氧堆肥过程中生物群落多样性及演替规律研究
- 批准号:31870501
- 批准年份:2018
- 资助金额:59.0 万元
- 项目类别:面上项目
流域农业和城镇用地变化对溪流底栖动物群落功能多样性的影响及机制
- 批准号:41771052
- 批准年份:2017
- 资助金额:69.0 万元
- 项目类别:面上项目
浙江良渚文化先民(动物)食物结构的稳定同位素分析
- 批准号:41102014
- 批准年份:2011
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
外来入侵植物空心莲子草对农田生态系统中节肢动物群落的影响研究
- 批准号:30871638
- 批准年份:2008
- 资助金额:32.0 万元
- 项目类别:面上项目
山东后李文化时期人和动物骨的稳定同位素分析
- 批准号:40702003
- 批准年份:2007
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Support for Vector Biology Training for Sustainable Control of Vector Borne diseases in East Africa
支持媒介生物学培训以可持续控制东非媒介传播疾病
- 批准号:
10675897 - 财政年份:2023
- 资助金额:
$ 21.73万 - 项目类别:
One-Health Approach to Study Human Fasciola hepatica Transmission and Inform Strategic Control
研究人类肝片形吸虫传播并为战略控制提供信息的单一健康方法
- 批准号:
10435287 - 财政年份:2022
- 资助金额:
$ 21.73万 - 项目类别:
Expanding the toolbox for tsetse control in Kenya
扩大肯尼亚采采蝇控制的工具箱
- 批准号:
10450231 - 财政年份:2022
- 资助金额:
$ 21.73万 - 项目类别:
Expanding the toolbox for tsetse control in Kenya
扩大肯尼亚采采蝇控制的工具箱
- 批准号:
10602508 - 财政年份:2022
- 资助金额:
$ 21.73万 - 项目类别:
One-Health Approach to Study Human Fasciola hepatica Transmission and Inform Strategic Control
研究人类肝片形吸虫传播并为战略控制提供信息的单一健康方法
- 批准号:
10612456 - 财政年份:2022
- 资助金额:
$ 21.73万 - 项目类别: